Clinical Trial Update: Clinical Outcomes of GENOSS PCB for Femoropopliteal Artery Disease

View source ↗

Summary

This clinical trial update discusses outcomes for the GENOSS PCB paclitaxel-coated balloon used in femoropopliteal artery disease; enrollment is by invitation.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Femoropopliteal Artery Disease
• Peripheral Artery Disease

Drugs mentioned

• GENOSS PCB (paclitaxel-coated balloon)

Snippet

Sponsor: Genoss Co., Ltd. | Conditions: PTA (Percutaneous Transluminal Angioplasty ), Femoropopliteal Artery Disease | Status: ENROLLING_BY_INVITATION